InvestorsHub Logo
Followers 116
Posts 2985
Boards Moderated 0
Alias Born 06/28/2014

Re: staccani post# 226970

Sunday, 05/12/2019 12:11:23 PM

Sunday, May 12, 2019 12:11:23 PM

Post# of 699486
Thanks Staccani: “The Company continues to make progress in its Phase 3 INTACT (INvestigation of TSC Against Cancerous Tumors) trial. It has completed the eight-patient open label dose-escalation run-in cohort and, with enrollment for this phase now closed, expects data on this group to be available this summer.”

DIFFERENT STROKES FOR DIFFERENT FOLKS


















DIFFERENT STROKES FOR DIFFERENT FOLKS

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News